Stockscreener 앱 받기
19.61
2.02%
-0.385
전일 마감가:
$19.99
열려 있는:
$19.88
하루 거래량:
5.52M
Relative Volume:
0.75
시가총액:
$13.38B
수익:
$125.68M
순이익/손실:
$4.81B
주가수익비율:
3.4699
EPS:
5.65
순현금흐름:
$-781.21M
1주 성능:
+4.13%
1개월 성능:
+21.13%
6개월 성능:
+70.61%
1년 성능:
+67.69%
1일 변동 폭
$19.30
$20.03
1주일 범위
$18.32
$20.09
52주 변동 폭
$8.73
$20.09
Roivant Sciences Ltd Stock (ROIV) Company Profile
명칭
Roivant Sciences Ltd
전화
441-295-5950
주소
7TH FLOOR, 50 BROADWAY, LONDON
ROIV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
19.59 | 13.65B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.26 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.99 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.15 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.40 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-02 | 개시 | Citigroup | Buy |
| 2025-07-10 | 재개 | Goldman | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2024-01-05 | 개시 | Piper Sandler | Overweight |
| 2023-12-12 | 개시 | Deutsche Bank | Buy |
| 2023-10-17 | 개시 | Guggenheim | Buy |
| 2023-06-08 | 개시 | BofA Securities | Neutral |
| 2022-10-27 | 개시 | JP Morgan | Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2022-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-12-15 | 개시 | Goldman | Buy |
| 2021-11-08 | 개시 | H.C. Wainwright | Buy |
| 2021-10-28 | 개시 | Citigroup | Buy |
| 2021-10-26 | 개시 | Cowen | Outperform |
| 2021-10-26 | 개시 | Jefferies | Buy |
| 2021-10-26 | 개시 | Truist | Buy |
모두보기
Roivant Sciences Ltd 주식(ROIV)의 최신 뉴스
Is Roivant Sciences Ltd. stock recession proof2025 Price Momentum & Weekly High Potential Alerts - newser.com
Is Roivant Sciences Ltd. (87S) stock safe for risk averse investorsRecession Risk & Fast Entry Momentum Trade Alerts - newser.com
Best data tools to analyze Roivant Sciences Ltd. stockJuly 2025 Weekly Recap & High Accuracy Investment Signals - newser.com
Will Roivant Sciences Ltd. stock reach Wall Street targetsTrade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com
Will Roivant Sciences Ltd. stock gain from government policiesProduct Launch & Daily Entry Point Alerts - newser.com
How to read the order book for Roivant Sciences Ltd.Weekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com
Top chart patterns to watch in Roivant Sciences Ltd.Dividend Hike & Daily Chart Pattern Signal Reports - newser.com
Why Roivant Sciences Ltd. (87S) stock attracts wealthy investorsFed Meeting & Advanced Technical Analysis Signals - newser.com
Chart based exit strategy for Roivant Sciences Ltd.Portfolio Performance Report & Pattern Based Trade Signal System - newser.com
Is Roivant Sciences Ltd. (87S) stock prepared for digital transitionIndex Update & Safe Entry Zone Tips - newser.com
Pier Capital LLC Reduces Holdings in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Hits New 52-Week High of $19.66, Up 85% - Markets Mojo
Transcend Capital Advisors LLC Purchases New Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (NASDAQ:ROIV) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
Roivant Sciences stock hits all-time high at 18.95 USD By Investing.com - Investing.com Australia
Roivant Sciences Ltd. stock prediction for this weekMarket Trend Review & Weekly Momentum Stock Picks - newser.com
Is Roivant Sciences Ltd. (87S) stock a contrarian opportunityIPO Watch & Safe Capital Preservation Plans - newser.com
Key metrics from Roivant Sciences Ltd.’s quarterly data2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
Can Roivant Sciences Ltd. rally from current levelsPortfolio Gains Summary & Safe Entry Zone Identification - newser.com
Can Roivant Sciences Ltd. (87S) stock double in coming yearsJuly 2025 Update & Consistent Profit Alerts - newser.com
Risk vs reward if holding onto Roivant Sciences Ltd.2025 Top Gainers & Verified Entry Point Signals - newser.com
Roivant Sciences stock hits all-time high at 18.95 USD - Investing.com
Will Roivant Sciences Ltd. (87S) stock outperform benchmarksBuy Signal & Weekly Setup with ROI Potential - newser.com
Y Intercept Hong Kong Ltd Acquires Shares of 271,903 Roivant Sciences Ltd. $ROIV - MarketBeat
Citigroup Raises Price Target for ROIV, Maintains Buy Rating | R - GuruFocus
Roivant Sciences (ROIV): Evaluating Valuation After Strong Share Price Momentum in Biotech - Yahoo Finance
Citi Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $25 - 富途牛牛
Will Roivant Sciences Ltd. stock outperform international peers2025 Winners & Losers & Free Technical Pattern Based Buy Signals - fcp.pa.gov.br
Roivant Sciences (NASDAQ:ROIV) Sets New 12-Month HighTime to Buy? - MarketBeat
Can Roivant Sciences Ltd. stock sustain revenue growthPortfolio Return Summary & Fast Moving Market Watchlists - fcp.pa.gov.br
Is Roivant Sciences Ltd. stock attractive for passive investorsPortfolio Profit Report & Community Verified Watchlist Alerts - Fundação Cultural do Pará
Roivant Sciences Ltd (ROIV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
1.71%
자본화:
|
볼륨(24시간):